IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tang Capital Management LLC

Q4 2013 Holdings

Filed 2014-02-14 | 14 holdings | $13.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$12.8M182,30099.0%
PDL Biopharma IncNOTE 2.875% 2/15/1569329YAE4$38.6K$25,974,0000.3%
Salix Pharmaceuticals IncCOM795435106$27.0K300,0000.2%
Opko Health IncNOTE 3.0% 2/1/3368375NAA1$17.1K$14,000,0000.1%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$15.6K938,5430.1%
Intermune IncNOTE 2.50% 9/15/1845884XAE3$10.6K$12,000,0000.1%
Oncogenex Pharmaceuticals IncCOM68230A106$8.6K1,033,1000.1%
Mannkind CorpCOM56400P201$5.6K1,070,4190.0%
Endocyte IncCOM29269A102$5.0K465,7630.0%
Sophiris BIO IncCOM83578Q209$1.9K500,0000.0%
Dendreon CorpCOM24823Q107$23879,6000.0%
Opko Health Inc(OPK)COM68375N103$9411,1950.0%
Ambit Biosciences CorpCOM02318X100$0460.0%